Gilead will charge the U.S. government, which funds programs like Medicaid, $390 per vial — or $2,340 for the shortest treatment plan. The company has set a higher price for patients with private insurance in the U.S., charging hospitals $520 a vial — or $3,120 per patient on a typical treatment course.
Coronavirus drug remdesivir to cost $3,120 per patient on private insurance
Prepare Now Before its too Late
Discover where products are available & compare prices
